Stinging Nettle

Stinging nettle leaves are rich in vitamin K. Vitamin K is a cofactor in the hepatic synthesis of clotting factors II, VII, IX, and X. Warfarin acts by inhibiting vitamin K epoxide reductase; increased dietary vitamin K intake via high-dose nettle supplementation can antagonize warfarin anticoagulation and reduce INR.

Monitor INR closely when initiating or discontinuing stinging nettle supplements in patients on warfarin. Advise patients to maintain consistent nettle intake rather than making abrupt changes. Consider a warfarin dose adjustment if nettle is used regularly in large quantities.

Aqueous extract of Urtica dioica exhibits hypotensive effects via NO-mediated vasorelaxation, calcium channel blocking activity, and diuretic action (natriuresis and increased urine output). These pharmacodynamic mechanisms are additive with antihypertensive drugs, and may cause excessive blood pressure reduction.

Monitor blood pressure regularly when patients on antihypertensive medications begin or increase stinging nettle supplementation. Advise patients to report symptoms of hypotension (dizziness, fainting, lightheadedness). Dose adjustment of antihypertensive may be required.

Urtica dioica leaf extract lowers blood glucose via multiple mechanisms: stimulates insulin secretion from pancreatic beta cells, acts as a PPARgamma agonist improving insulin sensitivity, inhibits alpha-glucosidase reducing carbohydrate absorption, and increases glucose uptake in peripheral tissues. Additive with antidiabetic agents, increasing hypoglycemia risk.

Monitor fasting blood glucose and HbA1c when patients on antidiabetic therapy add stinging nettle. Warn patients of hypoglycemia symptoms (shakiness, sweating, confusion). A clinical trial showed significant reductions in fasting glucose and HbA1c when 500 mg TID nettle extract was added to conventional therapy; dose adjustment of antidiabetics may be needed.

Urtica dioica root and leaf extracts possess diuretic properties (increased urine volume and sodium excretion). When combined with loop or thiazide diuretics, additive diuresis may occur, leading to dehydration, electrolyte disturbances (hyponatremia, hypokalemia), and orthostatic hypotension.

Caution co-administration of stinging nettle with diuretic medications. Monitor for signs of dehydration and electrolyte imbalance. Check serum electrolytes periodically and advise patients to maintain adequate fluid and salt intake. Avoid use in patients with severe fluid-electrolyte disorders.

Lithium is predominantly eliminated by the kidneys and its renal clearance is closely coupled to sodium handling. Stinging nettle acts as a diuretic, promoting sodium and water excretion. When sodium excretion is increased by diuretic effects, compensatory renal reabsorption of both sodium and lithium is triggered, leading to accumulation of lithium in the body and potential toxicity.

Avoid concurrent use of high-dose stinging nettle preparations in patients taking lithium unless carefully supervised. If used together, monitor lithium serum levels closely, assess for symptoms of lithium toxicity (tremor, nausea, polyuria, neurological signs), and ensure adequate sodium and fluid intake. Consider this a significant drug interaction requiring prescriber awareness.

Stinging nettle leaf has anti-inflammatory properties mediated through inhibition of pro-inflammatory cytokines (IL-1, IL-6, TNF-alpha) and NF-kappaB signaling. When combined with NSAIDs, there may be an additive anti-inflammatory effect, which can be clinically beneficial (allowing NSAID dose reduction) but may also increase the risk of adverse effects if NSAID doses are not reduced.

Co-administration of nettle with NSAIDs may provide enhanced anti-inflammatory benefit, particularly for arthritis, and some studies show patients can reduce NSAID doses. Monitor for additive GI adverse effects. Educate patients that while the combination may be beneficial, any change in NSAID dose should be made in consultation with a prescriber.

Stinging nettle leaves contain significant concentrations of Vitamin K (phylloquinone), which is the pharmacological target of warfarin. High or variable dietary Vitamin K intake antagonizes warfarin anticoagulation and reduces INR. Concentrated nettle supplements may provide clinically significant Vitamin K loads. Additionally, nettle flavonoids (quercetin, rutin) possess mild antiplatelet activity via a separate pathway, creating a complex and potentially offsetting dual effect on hemostasis.

Monitor INR when patients on warfarin use stinging nettle supplements, particularly concentrated extracts. Advise patients to maintain consistent (not variable) nettle intake to prevent INR fluctuations. High-dose nettle supplementation may necessitate warfarin dose titration. Patients should not self-adjust nettle doses without informing their prescriber.

Aqueous extracts of Urtica dioica root and leaf demonstrate acute hypotensive effects in experimental models via endothelium-dependent mechanisms including nitric oxide (NO) release and inhibition of angiotensin-converting enzyme (ACE). Urtica also produces diuretic and natriuretic effects that contribute to blood pressure reduction. Combined use with antihypertensive drugs creates pharmacodynamic synergism that may cause excessive blood pressure lowering (hypotension), particularly in elderly patients.

Monitor blood pressure regularly when adding stinging nettle to an antihypertensive regimen. Advise patients to report dizziness, lightheadedness, or syncope. Home blood pressure monitoring is recommended. Antihypertensive dose reduction may be necessary in patients with labile blood pressure.

Stinging nettle has well-documented diuretic properties, producing increased urine output via natriuretic and aquaretic mechanisms (aquaporin modulation, aldosterone inhibition). Combined use with pharmaceutical diuretics produces additive fluid and electrolyte loss, potentially causing dehydration, hypokalemia, hyponatremia, and hypotension. Patients on cardiac medications (digoxin, antiarrhythmics) are especially vulnerable to electrolyte disturbances.

Use with caution in patients on diuretic therapy. Monitor fluid balance, serum electrolytes (especially potassium), and renal function (BUN, creatinine). Ensure adequate hydration. Risk is higher in elderly patients and those with cardiac disease. Advise patients not to use concentrated nettle extracts as diuretic supplements without medical oversight.

Lithium is primarily excreted by the kidneys, and renal lithium clearance is tightly coupled to sodium reabsorption. Stinging nettle diuretic-natriuretic action increases sodium excretion, which reflexively triggers renal sodium (and lithium) reabsorption to maintain serum osmolality. The net effect is reduced renal lithium excretion and increased plasma lithium levels. Given lithium's narrow therapeutic index (therapeutic range 0.6-1.2 mmol/L), even modest plasma concentration increases can precipitate toxicity.

Avoid combining stinging nettle with lithium without close medical supervision. If used together, monitor serum lithium levels every 1-2 weeks initially. Advise patients on early signs of lithium toxicity: coarse tremor, thirst, polyuria, nausea, diarrhea. Ensure adequate sodium and fluid intake to prevent compensatory lithium retention.

Urtica dioica leaf and root extracts demonstrate alpha-glucosidase inhibitory activity and improvements in insulin sensitivity in clinical and preclinical studies. Aqueous extracts reduce fasting blood glucose and postprandial glucose excursions. When combined with antidiabetic pharmacotherapy, particularly insulin or sulfonylureas, additive hypoglycemic effects may increase the risk of hypoglycemia. Blood glucose-lowering effects are dose-dependent.

Monitor blood glucose closely when initiating stinging nettle supplements in diabetic patients on antidiabetic medications. Patients on insulin or sulfonylureas are at greatest risk of hypoglycemia. Advise patients to measure blood glucose more frequently at initiation and report hypoglycemic episodes. Dose adjustment of antidiabetic drugs may be required.

A clinical study in patients with acute arthritis demonstrated that stewed stinging nettle leaves enhanced the anti-inflammatory effect of diclofenac, allowing NSAID dose reductions while maintaining equivalent pain relief. Mechanistically, stinging nettle leaf extract suppresses pro-inflammatory cytokines (TNF-alpha, IL-1, IL-6) and NF-kB activation, complementing NSAID COX inhibition with separate inflammatory pathway blockade. This additive effect is pharmacodynamic and beneficial in arthritis management.

Stinging nettle leaf may be used as an adjunct to NSAIDs for inflammatory arthritis, potentially allowing NSAID dose reduction and thereby reducing NSAID-associated GI and cardiovascular risks. Discuss with the treating physician before reducing NSAID doses. Do not discontinue prescribed NSAIDs abruptly without medical guidance.